Mycosis fungoides diagnostic study of choice: Difference between revisions
Jump to navigation
Jump to search
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}}{{S.G.}} | {{CMG}}; {{AE}}{{S.G.}} | ||
== Overview == | == Overview == | ||
Mycosis fungoides is primarily diagnosed based on the clinical presentation. | |||
== Diagnostic Study of Choice == | == Diagnostic Study of Choice == | ||
Revision as of 13:00, 4 January 2019
|
Mycosis fungoides Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Mycosis fungoides diagnostic study of choice On the Web |
|
American Roentgen Ray Society Images of Mycosis fungoides diagnostic study of choice |
|
Risk calculators and risk factors for Mycosis fungoides diagnostic study of choice |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sogand Goudarzi, MD [2]
Overview
Mycosis fungoides is primarily diagnosed based on the clinical presentation.
Diagnostic Study of Choice
Mycosi fungoides must be performed when:[1]
- The patient presents with symptomatic progressive skin lesions such as: patches, plaques, tumors, and erytheroderma, and a poorer prognosis in later stages.
- There is no single diagnostic study of choice for the diagnosis of mycosis fungoides, and mycosis fungoides can be diagnosed difficult by nonspecific skin presentation.
- Mycosis fungoides is primarily diagnosed based on the clinical presentation.